ES2489715T3 - Procedimiento para la produccíón de colágeno humano de tipo II - Google Patents

Procedimiento para la produccíón de colágeno humano de tipo II Download PDF

Info

Publication number
ES2489715T3
ES2489715T3 ES11002048.4T ES11002048T ES2489715T3 ES 2489715 T3 ES2489715 T3 ES 2489715T3 ES 11002048 T ES11002048 T ES 11002048T ES 2489715 T3 ES2489715 T3 ES 2489715T3
Authority
ES
Spain
Prior art keywords
dna
protein
triple helix
helix structure
collagen type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11002048.4T
Other languages
English (en)
Spanish (es)
Inventor
Tetsuo Kase
Akio Kimura
Hiroshi Ueyama
Mizuki Nishihara
Hiroshi Kisaki
Hiroyuki Keshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuso Pharmaceutical Industries Ltd
Osaka Prefecture
Original Assignee
Fuso Pharmaceutical Industries Ltd
Osaka Prefecture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuso Pharmaceutical Industries Ltd, Osaka Prefecture filed Critical Fuso Pharmaceutical Industries Ltd
Application granted granted Critical
Publication of ES2489715T3 publication Critical patent/ES2489715T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES11002048.4T 2005-03-31 2006-03-31 Procedimiento para la produccíón de colágeno humano de tipo II Active ES2489715T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005102999 2005-03-31
JP2005102999 2005-03-31

Publications (1)

Publication Number Publication Date
ES2489715T3 true ES2489715T3 (es) 2014-09-02

Family

ID=37073520

Family Applications (2)

Application Number Title Priority Date Filing Date
ES11002048.4T Active ES2489715T3 (es) 2005-03-31 2006-03-31 Procedimiento para la produccíón de colágeno humano de tipo II
ES06730889T Active ES2387467T3 (es) 2005-03-31 2006-03-31 Procedimientos de producción de proteínas que tienen estructura helicoidal triple

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES06730889T Active ES2387467T3 (es) 2005-03-31 2006-03-31 Procedimientos de producción de proteínas que tienen estructura helicoidal triple

Country Status (12)

Country Link
US (1) US9018354B2 (da)
EP (3) EP2390326B1 (da)
JP (1) JP4892474B2 (da)
KR (1) KR101304735B1 (da)
CN (1) CN101171334B (da)
AU (1) AU2006231795B9 (da)
CA (1) CA2602611C (da)
DK (2) DK2390326T3 (da)
ES (2) ES2489715T3 (da)
HK (1) HK1164917A1 (da)
PT (2) PT2390326E (da)
WO (1) WO2006106970A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009331326B2 (en) * 2008-12-22 2014-09-18 Fuso Pharmaceutical Industries, Ltd. Expression vector for producing protein derived from foreign gene in large quantity using animal cells, and use thereof
WO2010074081A1 (ja) 2008-12-22 2010-07-01 国立大学法人北海道大学 三重螺旋構造を有するタンパク質、およびその製造方法
JP2011130725A (ja) * 2009-12-25 2011-07-07 Contig I:Kk Lnaオリゴヌクレオチドとそれを含有する化粧品
FR2997083B1 (fr) 2012-10-19 2014-12-12 Nvh Medicinal Proteines recombinantes derivees du collagene a activite de liaison au facteur willebrand
US10373702B2 (en) * 2014-03-27 2019-08-06 Massachusetts Institute Of Technology Water-soluble trans-membrane proteins and methods for the preparation and use thereof
CN111087478B (zh) * 2020-01-10 2022-04-05 杭州嘉颜生物医药科技有限公司 一种重组胶原蛋白及其制备方法
CN114920826B (zh) * 2022-06-15 2023-04-25 江南大学 Ⅲ型类人胶原蛋白及其编码基因、表达载体和重组酵母菌
CN118255874B (zh) * 2024-05-31 2024-08-20 北京鑫康辰医学科技发展有限公司 一种天然活性胶原蛋白及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01107857A (ja) 1987-10-21 1989-04-25 Mitsubishi Electric Corp 超電導物質の分離方法
US20020142391A1 (en) * 1991-06-12 2002-10-03 Kivirikko Kari I. Synthesis of human procollagens and collagens in recombinant DNA systems
US5593859A (en) 1991-10-23 1997-01-14 Thomas Jefferson University Synthesis of human procollagens and collagens in recombinant DNA systems
ES2143478T5 (es) * 1991-10-23 2006-05-16 Thomas Jefferson University Sintesis de procolagenos y colagenos humanos en sistemas de adn de recombinacion.
US20020098578A1 (en) * 1992-10-22 2002-07-25 Darwin J. Prockop Synthesis of human procollagens and collagens in recombinant dna systems
JPH0823979A (ja) 1994-07-15 1996-01-30 Terumo Corp ヒト・コラーゲン発現ベクターおよびヒト・コラーゲンの製造方法
AU3056697A (en) * 1996-04-12 1997-11-07 Academy Of Finland Synthesis of human procollagens and collagens in recombinant dna systems
JP3582965B2 (ja) 1996-08-23 2004-10-27 株式会社イムノ・ジャパン 哺乳動物細胞用発現ベクター
JPH11178574A (ja) 1997-12-22 1999-07-06 Toyota Central Res & Dev Lab Inc 新規コラーゲン様タンパク質
JP2002325584A (ja) 2000-11-30 2002-11-12 Japan Science & Technology Corp 組換えヒトiv型コラーゲンペプチドとその製造方法
JP2004016144A (ja) 2002-06-18 2004-01-22 Japan Science & Technology Corp ヒト・コラーゲンを産生する形質転換カイコ

Also Published As

Publication number Publication date
EP2390326A1 (en) 2011-11-30
CA2602611A1 (en) 2006-10-12
DK1870460T3 (da) 2012-09-03
US20120172577A1 (en) 2012-07-05
KR20070121809A (ko) 2007-12-27
EP1870460B1 (en) 2012-05-30
EP2383338B1 (en) 2016-10-19
EP1870460A1 (en) 2007-12-26
WO2006106970A1 (ja) 2006-10-12
EP2390326B1 (en) 2014-07-09
AU2006231795A1 (en) 2006-10-12
HK1164917A1 (en) 2012-09-28
AU2006231795B2 (en) 2012-02-16
CN101171334B (zh) 2013-03-27
KR101304735B1 (ko) 2013-09-05
EP2383338A1 (en) 2011-11-02
US9018354B2 (en) 2015-04-28
EP1870460A4 (en) 2008-12-24
AU2006231795B9 (en) 2012-04-12
PT1870460E (pt) 2012-06-21
PT2390326E (pt) 2014-08-05
EP1870460B9 (en) 2012-12-05
CN101171334A (zh) 2008-04-30
JPWO2006106970A1 (ja) 2008-09-25
ES2387467T3 (es) 2012-09-24
DK2390326T3 (da) 2014-10-13
CA2602611C (en) 2015-09-29
JP4892474B2 (ja) 2012-03-07

Similar Documents

Publication Publication Date Title
ES2489715T3 (es) Procedimiento para la produccíón de colágeno humano de tipo II
CO5601037A2 (es) Anticuerpos anti-a beta y sus usos
AR047347A1 (es) Miembros de la familia cry9 de bacillus
UA110599C2 (uk) Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку
RU2010108308A (ru) Способ получения гетерогенных белков
AR049177A1 (es) Polipeptidos y conjugados de interferon-alfa
ES2597877T3 (es) Promotor mejorado y método para la producción de L-lisina mediante el uso del mismo
MX338183B (es) Polipeptidos aislados, polinucleotidos que los codifican, plantas transgenicas quie expresan los mismos y metodos para usarlos.
AR040446A1 (es) Defensinas de plantas
MX2021014057A (es) Polipéptidos de sintasas de cannabinoides optimizados.
MX2021012671A (es) Métodos y materiales para la producción de proteínas.
CO5580165A1 (es) Vacunas de rotavirus modificado
ATE493503T1 (de) Verfahren zur fermentativen herstellung von proteinen
JP2008505626A5 (da)
ATE445009T1 (de) Signalpeptid zur herstellung eines polypeptids
AR114287A2 (es) Constructo de un gen quimérico aislado; polipéptido codificado por dicho constructo; y método para conferir a una planta tolerancia a sequía, alta salinidad y congelamiento, excluida la planta obtenida por dicho método
RU2016152429A (ru) Меченый антиген е гепаднавируса и его применение в скрининге противовирусных веществ
ES2603128T3 (es) Microorganismo con productividad potenciada de L-lisina y procedimiento de producción de L-lisina usando el mismo
AR043862A1 (es) Procedimiento para la obtencion de estirpes celulares de mastocitos a partir de tejidos de cerdo y procedimiento para la produccion de moleculas de tipo de la heparina
ES2562919T3 (es) Proteína y secuencia de ADN que codifica una actividad del tipo de la subtilisina adaptada al frío
AR047590A1 (es) Alteracion de la estructura de la raiz durante el desarrollo de la planta
ES2525317T3 (es) Producción recombinante de inhibidores de la fusión antivirales peptídicos
ES2562664T3 (es) Nuevo sistema de selección
AU2007208928A8 (en) Transgenic plant transformed with stress-responsive gene
WO2004034780A3 (es) Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos